Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30366356 | 0.93 | FAAH (0.44) | ALDH1A1FAAHMGLLCYP19A1TBXAS1 | |
| SCHEMBL31664989 | 0.81 | ALDH1A1 (0.50) | ALDH1A1ALOX15FAAHMGLLTDP1 | |
| SCHEMBL395689 | 0.81 | MAPT (0.44) | FAAHMGLLCYP19A1TBXAS1CYP24A1 | |
| SCHEMBL10506862 | 0.81 | KMT2A (0.48) | ALDH1A1CYP19A1POLBKDM4E | |
| SCHEMBL16486800 | 0.81 | TBXAS1 (0.42) | ALDH1A1ALOX15FAAHMGLLCYP19A1 | |
| SCHEMBL15763697 | 0.81 | ELANE (0.55) | ALDH1A1L3MBTL1 | |
| SCHEMBL1424751 | 0.80 | CYP19A1 (0.47) | FAAHMGLLCYP19A1TBXAS1CYP24A1 | |
| SCHEMBL20572807 | 0.80 | MAPT (0.43) | FAAHMGLLCYP19A1TBXAS1CYP24A1 | |
| SCHEMBL10118094 | 0.79 | ALDH1A1 (0.54) | ALDH1A1TBXAS1POLBL3MBTL1KDM4E | |
| SCHEMBL11277690 | 0.77 | ALDH1A1 (0.61) | ALDH1A1ALOX15NAPRTTDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091996-A1 | 2-(1H-IMIDAZOLE-1-CARBONYL)BENZOIC ACID AS AN ANTICANCER COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | claimed |
| US-12172966-B1 | 2-(1H-imidazole-1-carbonyl)benzoic acid as an anticancer compound | King Faisal University (SA) | 2024-12-24 | — | — | US | claimed |
| US-20250091996-A1 | 2-(1H-IMIDAZOLE-1-CARBONYL)BENZOIC ACID AS AN ANTICANCER COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | disclosed |
| US-20250091996-A1 | 2-(1H-IMIDAZOLE-1-CARBONYL)BENZOIC ACID AS AN ANTICANCER COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | disclosed |
| US-20250091996-A1 | 2-(1H-IMIDAZOLE-1-CARBONYL)BENZOIC ACID AS AN ANTICANCER COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | disclosed |
| US-12172966-B1 | 2-(1H-imidazole-1-carbonyl)benzoic acid as an anticancer compound | King Faisal University (SA) | 2024-12-24 | — | — | US | disclosed |
| US-12172966-B1 | 2-(1H-imidazole-1-carbonyl)benzoic acid as an anticancer compound | King Faisal University (SA) | 2024-12-24 | — | — | US | disclosed |
| US-12172966-B1 | 2-(1H-imidazole-1-carbonyl)benzoic acid as an anticancer compound | King Faisal University (SA) | 2024-12-24 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12172966-B1 | 2-(1H-imidazole-1-carbonyl)benzoic acid as an anticancer compound | BAK1, BET1, NFKBIA | ALDH1A1 288/4885ALOX15 3082/4885FAAH 3774/4885 |
| US-20250091996-A1 | 2-(1H-IMIDAZOLE-1-CARBONYL)BENZOIC ACID AS AN ANTICANCER COMPOUND | BAK1, BET1, NFKBIA | ALDH1A1 288/4885ALOX15 3082/4885FAAH 3774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.